Effect of N-803 on B Cell Follicles in Antiretroviral Treated HIV Disease
Latest Information Update: 05 Apr 2024
At a glance
- Drugs Nogapendekin alfa inbakicept (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions
- 12 Jan 2023 Status changed from active, no longer recruiting to completed.
- 06 Jul 2022 Planned primary completion date changed from 1 Feb 2023 to 18 Jul 2022.
- 06 Jul 2022 Status changed from recruiting to active, no longer recruiting.